MRNA: Redburn reiterates sell, PT 81
Redburn calls the Phase 3 melanoma vaccine result “a great result,” but says the stock prices in broad multi-tumor use without supporting data.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.